Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001860782-24-000116
Filing Date
2024-11-12
Accepted
2024-11-12 16:12:02
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsvt-20240930.htm   iXBRL 10-Q 1354415
2 EX-31.1 tsvt-q3202410xqexhibit311cb.htm EX-31.1 8941
3 EX-31.2 tsvt-q3202410xqexhibit312ve.htm EX-31.2 9032
4 EX-32.1 tsvt-q3202410xqexhibit321.htm EX-32.1 5785
  Complete submission text file 0001860782-24-000116.txt   7514846

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20240930.xsd EX-101.SCH 63831
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tsvt-20240930_cal.xml EX-101.CAL 72648
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tsvt-20240930_def.xml EX-101.DEF 315212
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20240930_lab.xml EX-101.LAB 667581
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20240930_pre.xml EX-101.PRE 474231
83 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20240930_htm.xml XML 1056173
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40791 | Film No.: 241448256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)